Exchange: NASDAQ·Updated 07:30 PM EST

MNOV News

News
all
press releases
MediciNova (MNOV) Reports Q3 Loss, Misses Revenue Estimates
MediciNova (MNOV) delivered earnings and revenue surprises of 0.00% and -7.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MediciNova (MNOV) Reports Q3 Loss, Misses Revenue Estimates
MediciNova (MNOV) delivered earnings and revenue surprises of 0.00% and -7.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Gyre Therapeutics, Inc. (GYRE) delivered earnings and revenue surprises of +126.67% and +15.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Five smaller stocks with market caps above $100 million beat MRNA’s monthly gain: INDP rose 249%, CYPH 124%, MNOV 85%, GRAL 58% and SRZN 53%.
Stocktwits
MediciNova (MNOV) delivered earnings and revenue surprises of +16.67% and +205.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MaxCyte (MXCT) delivered earnings and revenue surprises of +33.33% and +11.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Alector (ALEC) delivered earnings and revenue surprises of +12.50% and +283.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MediciNova (NASDAQ:MNOV) will be releasing earnings after the market closes on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-medicinova-inc-stock...
MarketBeat
D. Boral Capital restated a "buy" rating and issued a $9.00 price target on shares of MediciNova in a report on Monday...
MarketBeat
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totaling 168,023 shares, a decline of 16.4% from the March...
MarketBeat
Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm...
MarketBeat

Advertisement|Remove ads.